Bioterrorism: is it a real threat?

Medical Microbiology and Immunology
René Gottschalk, Wolfgang Preiser

Abstract

The Geneva Protocol of 1925 commits the signatory nations to refraining from the use of biological weapons. However, the terrorist assaults of September 2001 and, subsequently, the anthrax-containing letters are cause for great concerns: new threats to the security of nations are expected, as terrorist organizations seem to increasingly explore novel ways of spreading terror. In this context, naturally emerging diseases such as SARS, monkeypox or West Nile fever assume new importance because it is difficult to distinguish between natural epidemics and possible bioweapon assaults. Great efforts on the part of governments and public health authorities are necessary to counteract these threats.

References

Jun 16, 2001·The New England Journal of Medicine·D NashUNKNOWN 1999 West Nile Outbreak Response Working Group
Aug 17, 2001·Journal of Virology·A Müllbacher, M Lobigs
Oct 26, 2001·The Journal of Infection·R C Spencer, N F Lightfoot
Nov 13, 2001·The New England Journal of Medicine·L M BushC C Johnson
Feb 9, 2002·BMJ : British Medical Journal·Nicholas J BeechingRobert C Spencer
Mar 19, 2002·Emerging Infectious Diseases·Lisa D RotzJames M Hughes
Oct 25, 2002·Emerging Infectious Diseases·Daniel B JerniganUNKNOWN National Anthrax Epidemiologic Investigation Team
Apr 10, 2003·Intervirology·B LudwigW Preiser
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thom A MayerJames Earls
May 27, 2003·Science·Chris Dye, Nigel Gay
Dec 17, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A BergerW Preiser
Jan 15, 2004·The Lancet Infectious Diseases·Daniel B Di Giulio, Paul B Eckburg
Jan 23, 2004·The New England Journal of Medicine·Kurt D ReedInger K Damon
Mar 26, 2004·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·James B PetroJack A McNulty
Apr 14, 2004·Emerging Infectious Diseases·Dena M BravataDouglas K Owens
Apr 28, 2004·Emerging Infectious Diseases·Jeannette GuarnerUNKNOWN Veterinary Monkeypox Virus Working Group
Apr 29, 2004·Emerging Infectious Diseases·Hiroshi TakahashiTakeshi Kurata
May 21, 2004·The New England Journal of Medicine·Louise Richardson
May 26, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Sergey N Rumyantsev
May 29, 2004·Trends in Microbiology·Arturo Casadevall, Liise-anne Pirofski

❮ Previous
Next ❯

Citations

Feb 14, 2009·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·René GottschalkW Biederbick
Dec 9, 2010·Influenza and Other Respiratory Viruses·P DickmannR Gottschalk
Dec 25, 2009·Pharmazie in unserer Zeit·August Stich, René Gottschalk

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

California State Journal of Medicine
Ostomy/wound Management
L van Rijswijk, D Gottlieb
General Hospital Psychiatry
R B FlanneryW Penk
© 2021 Meta ULC. All rights reserved